{"rows":[{"id":5785,"title":"Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics.","authors":"Petranker R, Syed OA, Sobolenko V, Giacobbe P, Kruger DJ, Aday JS, Lake S, Lucas P","journal":"The International journal on drug policy","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105459","pubmed_id":"42566966","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42566966/","substance_tags":"psilocybin","topic_tags":"Microdosing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-08-09 01:20:07","last_checked":"2026-10-08 01:20:08","bibtex":null,"source_record_id":"PMID:42566966","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42566966/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42566966","source_url":"https://pubmed.ncbi.nlm.nih.gov/42566966/","doi":"10.1016/j.drugpo.2026.105459","pmid":"42566966","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5680,"title":"Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.","authors":"Gagnon F, Philibert A, Carignan B, Labonté E, Dufresne Y","journal":"The International journal on drug policy","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105427","pubmed_id":"42424668","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42424668/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-10 01:20:03","last_checked":"2026-09-08 01:20:06","bibtex":null,"source_record_id":"PMID:42424668","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42424668/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42424668","source_url":"https://pubmed.ncbi.nlm.nih.gov/42424668/","doi":"10.1016/j.drugpo.2026.105427","pmid":"42424668","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2633,"title":"Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.","authors":"Wark C, Galliher JF","journal":"The International journal on drug policy","publication_date":"2010-05-01","publication_year":2010,"doi":"10.1016/j.drugpo.2009.08.004","pubmed_id":"19744846","openalex_id":"https://openalex.org/W2054460669","source_url":"https://pubmed.ncbi.nlm.nih.gov/19744846/","substance_tags":"psilocybin","topic_tags":"Adolescents","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:19744846","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/19744846/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:19744846","source_url":"https://pubmed.ncbi.nlm.nih.gov/19744846/","doi":"10.1016/j.drugpo.2009.08.004","pmid":"19744846","publication_date":"2010-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2628,"title":"Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.","authors":"Riley S, Thompson J, Griffin C","journal":"The International journal on drug policy","publication_date":"2010-11-01","publication_year":2010,"doi":"10.1016/j.drugpo.2010.07.001","pubmed_id":"20810266","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/20810266/","substance_tags":"psilocybin,psilocin","topic_tags":"Aging,Spirituality,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:20810266","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/20810266/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:20810266","source_url":"https://pubmed.ncbi.nlm.nih.gov/20810266/","doi":"10.1016/j.drugpo.2010.07.001","pmid":"20810266","publication_date":"2010-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2335,"title":"Narrative identity, rationality, and microdosing classic psychedelics.","authors":"Webb M, Copes H, Hendricks PS","journal":"The International journal on drug policy","publication_date":"2019-08-01","publication_year":2019,"doi":"10.1016/j.drugpo.2019.04.013","pubmed_id":"31071597","openalex_id":"https://openalex.org/W2944038128","source_url":"https://pubmed.ncbi.nlm.nih.gov/31071597/","substance_tags":"psilocybin","topic_tags":"Anxiety,Microdosing,Wellbeing,Creativity","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31071597","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31071597/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31071597","source_url":"https://pubmed.ncbi.nlm.nih.gov/31071597/","doi":"10.1016/j.drugpo.2019.04.013","pmid":"31071597","publication_date":"2019-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2333,"title":"Psychedelic-assisted therapies: The past, and the need to move forward responsibly.","authors":"Gardner J, Carter A, O'Brien K, Seear K","journal":"The International journal on drug policy","publication_date":"2019-08-01","publication_year":2019,"doi":"10.1016/j.drugpo.2019.05.019","pubmed_id":"31136924","openalex_id":"https://openalex.org/W2945745191","source_url":"https://pubmed.ncbi.nlm.nih.gov/31136924/","substance_tags":"psilocybin","topic_tags":"Addiction,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31136924","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31136924/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31136924","source_url":"https://pubmed.ncbi.nlm.nih.gov/31136924/","doi":"10.1016/j.drugpo.2019.05.019","pmid":"31136924","publication_date":"2019-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2315,"title":"Microdosing psychedelics: Motivations, subjective effects and harm reduction.","authors":"Lea T, Amada N, Jungaberle H, Schecke H, Klein M","journal":"The International journal on drug policy","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1016/j.drugpo.2019.11.008","pubmed_id":"31778967","openalex_id":"https://openalex.org/W2990036135","source_url":"https://pubmed.ncbi.nlm.nih.gov/31778967/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Microdosing,Wellbeing,Clinical Trial,Randomized Controlled Trial,Observational Study","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:31778967","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31778967/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31778967","source_url":"https://pubmed.ncbi.nlm.nih.gov/31778967/","doi":"10.1016/j.drugpo.2019.11.008","pmid":"31778967","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2218,"title":"Making \"bad trips\" good: How users of psychedelics narratively transform challenging trips into valuable experiences.","authors":"Gashi L, Sandberg S, Pedersen W","journal":"The International journal on drug policy","publication_date":"2021-01-01","publication_year":2021,"doi":"10.1016/j.drugpo.2020.102997","pubmed_id":"33080454","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/33080454/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33080454","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33080454/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33080454","source_url":"https://pubmed.ncbi.nlm.nih.gov/33080454/","doi":"10.1016/j.drugpo.2020.102997","pmid":"33080454","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1918,"title":"Rethinking enhancement substance use: A critical discourse studies approach.","authors":"Askew R, Williams L","journal":"The International journal on drug policy","publication_date":"2021-09-01","publication_year":2021,"doi":"10.1016/j.drugpo.2020.102994","pubmed_id":"33272772","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/33272772/","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33272772","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33272772/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33272772","source_url":"https://pubmed.ncbi.nlm.nih.gov/33272772/","doi":"10.1016/j.drugpo.2020.102994","pmid":"33272772","publication_date":"2021-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1917,"title":"Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.","authors":"Liokaftos D","journal":"The International journal on drug policy","publication_date":"2021-09-01","publication_year":2021,"doi":"10.1016/j.drugpo.2020.103099","pubmed_id":"33518382","openalex_id":"https://openalex.org/W3123414763","source_url":"https://pubmed.ncbi.nlm.nih.gov/33518382/","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33518382","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33518382/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33518382","source_url":"https://pubmed.ncbi.nlm.nih.gov/33518382/","doi":"10.1016/j.drugpo.2020.103099","pmid":"33518382","publication_date":"2021-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1878,"title":"Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.","authors":"Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS","journal":"The International journal on drug policy","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.drugpo.2021.103380","pubmed_id":"34329952","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/34329952/","substance_tags":"psilocybin","topic_tags":"Addiction,Aging,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:34329952","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34329952/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34329952","source_url":"https://pubmed.ncbi.nlm.nih.gov/34329952/","doi":"10.1016/j.drugpo.2021.103380","pmid":"34329952","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1877,"title":"Use of hallucinogens in Slovakia: Does it differ from global trends?","authors":"Lukačovič M, Masaryk R","journal":"The International journal on drug policy","publication_date":"2021-12-01","publication_year":2021,"doi":"10.1016/j.drugpo.2021.103385","pubmed_id":"34364200","openalex_id":"https://openalex.org/W3193012633","source_url":"https://pubmed.ncbi.nlm.nih.gov/34364200/","substance_tags":"psilocybin","topic_tags":"Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:34364200","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34364200/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34364200","source_url":"https://pubmed.ncbi.nlm.nih.gov/34364200/","doi":"10.1016/j.drugpo.2021.103385","pmid":"34364200","publication_date":"2021-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1862,"title":"United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.","authors":"Barnett BS, Parker SE, Weleff J","journal":"The International journal on drug policy","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1016/j.drugpo.2021.103473","pubmed_id":"34624734","openalex_id":"https://openalex.org/W3203419443","source_url":"https://pubmed.ncbi.nlm.nih.gov/34624734/","substance_tags":"psilocybin","topic_tags":"Addiction,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:34624734","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34624734/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34624734","source_url":"https://pubmed.ncbi.nlm.nih.gov/34624734/","doi":"10.1016/j.drugpo.2021.103473","pmid":"34624734","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1685,"title":"Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.","authors":"Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK","journal":"The International journal on drug policy","publication_date":"2022-10-01","publication_year":2022,"doi":"10.1016/j.drugpo.2022.103816","pubmed_id":"35964449","openalex_id":"https://openalex.org/W4290990311","source_url":"https://pubmed.ncbi.nlm.nih.gov/35964449/","substance_tags":"psilocybin","topic_tags":"Aging,Observational Study,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:35964449","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35964449/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35964449","source_url":"https://pubmed.ncbi.nlm.nih.gov/35964449/","doi":"10.1016/j.drugpo.2022.103816","pmid":"35964449","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1511,"title":"Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent.","authors":"Simpson GHR, Chatwin C, van Hellemont E","journal":"The International journal on drug policy","publication_date":"2023-04-01","publication_year":2023,"doi":"10.1016/j.drugpo.2023.103973","pubmed_id":"36863288","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36863288/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:36863288","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36863288/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36863288","source_url":"https://pubmed.ncbi.nlm.nih.gov/36863288/","doi":"10.1016/j.drugpo.2023.103973","pmid":"36863288","publication_date":"2023-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1496,"title":"Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.","authors":"Palamar JJ, Le A, Cleland CM, Keyes KM","journal":"The International journal on drug policy","publication_date":"2023-05-01","publication_year":2023,"doi":"10.1016/j.drugpo.2023.104001","pubmed_id":"36934660","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36934660/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:36934660","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36934660/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36934660","source_url":"https://pubmed.ncbi.nlm.nih.gov/36934660/","doi":"10.1016/j.drugpo.2023.104001","pmid":"36934660","publication_date":"2023-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1060,"title":"The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.","authors":"Lake S, Lucas P","journal":"The International journal on drug policy","publication_date":"2024-08-01","publication_year":2024,"doi":"10.1016/j.drugpo.2024.104507","pubmed_id":"38936219","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/38936219/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:38936219","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38936219/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38936219","source_url":"https://pubmed.ncbi.nlm.nih.gov/38936219/","doi":"10.1016/j.drugpo.2024.104507","pmid":"38936219","publication_date":"2024-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":978,"title":"Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.","authors":"Anderson K, Elf P, Isham A","journal":"The International journal on drug policy","publication_date":"2024-11-01","publication_year":2024,"doi":"10.1016/j.drugpo.2024.104571","pubmed_id":"39241438","openalex_id":"https://openalex.org/W4402279238","source_url":"https://pubmed.ncbi.nlm.nih.gov/39241438/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39241438","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39241438/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39241438","source_url":"https://pubmed.ncbi.nlm.nih.gov/39241438/","doi":"10.1016/j.drugpo.2024.104571","pmid":"39241438","publication_date":"2024-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":363,"title":"Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.","authors":"Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT","journal":"The International journal on drug policy","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1016/j.drugpo.2025.104938","pubmed_id":"40803962","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40803962/","substance_tags":"psilocybin","topic_tags":"Addiction,Safety","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:40803962","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40803962/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40803962","source_url":"https://pubmed.ncbi.nlm.nih.gov/40803962/","doi":"10.1016/j.drugpo.2025.104938","pmid":"40803962","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":295,"title":"Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.","authors":"Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O","journal":"The International journal on drug policy","publication_date":"2026-02-01","publication_year":2026,"doi":"10.1016/j.drugpo.2025.105105","pubmed_id":"41389560","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41389560/","substance_tags":"psilocybin","topic_tags":"Anxiety,Safety","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41389560","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41389560/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41389560","source_url":"https://pubmed.ncbi.nlm.nih.gov/41389560/","doi":"10.1016/j.drugpo.2025.105105","pmid":"41389560","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}}],"total":22,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"The International journal on drug policy","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}